ペンシルベニアにおけるCOPDの臨床試験
ペンシルベニア内の拠点で、COPDに関する33件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, Philadelphia
- Research Site, Philadelphia
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Suburban Research Associates - Media- Site Number : 8400143, Media
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research Associates of Central PA, LLC, DuBois
- DM Clinical Research - Philadelphia, Philadelphia
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/09/30更新 · NCT07684820A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50002, DuBois
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/25更新 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Clinical Research Associates of Central PA, DuBois
被験者募集中第2相
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Temple University Hospital- Site Number : 8400059, Philadelphia
- Preferred Primary Care Physicians - Pleasant Hills- Site Number : 8400092, Pittsburgh
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Clinical Research Associates of Central Pennsylvania- Site Number : 8400002, DuBois
被験者募集中第4相
40歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07053423An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
- Allegheny General Hospital, Pittsburgh
- 他1件
被験者募集中
40歳〜80歳 · 全性別 · 2026/09/17更新 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, DuBois
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, DuBois
- Research Site, Philadelphia
- 他4件
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Temple University, Philadelphia
- University of Pittsburgh, Pittsburgh
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Horsham
- Research Site, Pittsburgh
- Research Site, Sayre
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, DuBois
- Research Site, Philadelphia
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- UPMC Montefiore Hospital, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06603246COPD Exacerbation Follow Up
- Thomas Jefferson University, Philadelphia
被験者募集中観察研究
40歳以上 · 全性別 · 2026/09/02更新 · NCT07118306A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Research Associates of Central PA, LLC, DuBois
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694STRIVE Post-Market Registry Study
- Penn State Milton S. Hershey Medical Center, Hershey
- Temple University, Philadelphia
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- Reading Hospital, West Reading
被験者募集中第3相
40歳以上 · 全性別 · 2026/07/31更新 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, DuBois
- GSK Investigational Site, West Chester
被験者募集中第3相
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Temple University Hospital, Philadelphia
被験者募集中
22歳以上 · 全性別 · 2026/06/23更新 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Temple University, Philadelphia
被験者募集中観察研究健康なボランティア歓迎
30歳〜55歳 · 全性別 · 2026/06/03更新 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Penn Highlands - Lung Innovations/Clinical Research Associates, DuBois
- Temple University - Temple Lung Center, Philadelphia
- University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center, Pittsburgh
被験者募集中
40歳〜80歳 · 全性別 · 2026/04/28更新 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Clinical Research Associates of Central Pennsylvania, DuBois
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中
40歳〜84歳 · 全性別 · 2026/04/24更新 · NCT06891755Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2026/04/21更新 · NCT05746039Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
- Thomas Jefferson University, Philadelphia
被験者募集中観察研究
50歳〜80歳 · 全性別 · 2026/03/03更新 · NCT06974981Supporting Evidence-based Responses to Emotional Needs in Emphysema
- University of Pennsylvania, Philadelphia
被験者募集中
18歳以上 · 全性別 · 2026/01/30更新 · NCT06600126Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- UPMC Presbyterian, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
被験者募集中第1/2相
18歳〜60歳 · 全性別 · 2026/01/13更新 · NCT03500731Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
被験者募集中健康なボランティア歓迎
8歳〜70歳 · 全性別 · 2025/10/24更新 · NCT06512064Emphysema Research Registry and Biosample Repository
- University of Pittsburgh Emphysema/COPD Research Center, Pittsburgh
被験者募集中観察研究健康なボランティア歓迎
21歳以上 · 全性別 · 2025/09/25更新 · NCT00307281Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Clinical Research Associates of Central PA, DuBois
- US Digestive Health at Lancaster, Lancaster
- Temple University, Philadelphia
- 他2件
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077Temple Health Chest Initiative (THCI 2.0)
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
被験者募集中観察研究健康なボランティア歓迎
50歳〜80歳 · 全性別 · 2025/04/18更新 · NCT06933758myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- St. Luke's University Health Network, Bethlehem
- Clinical Research Associates of Central Pennsylvania, DuBois
- Jeanes Hospital, Philadelphia
- 他2件
被験者募集中
30歳以上 · 全性別 · 2025/02/06更新 · NCT05204888ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。